Statement From Former Pfizer CEO Ian Read and Former Pfizer CFO Frank D’Amelio Regarding Starboard Value
NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) — Guggenheim Securities, LLC is issuing a statement on behalf of former Pfizer…
Pharmaceuticals, Biotechnology and Life Sciences
NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) — Guggenheim Securities, LLC is issuing a statement on behalf of former Pfizer…
Strategic Agreements Unite Companies to Enhance Operational Synergies in the California Cannabis MarketSALINAS, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) —…
LOS ANGELES, Oct. 09, 2024 (GLOBE NEWSWIRE) — Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announced today…
RADNOR, Pa., Oct. 09, 2024 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today…
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. 09, 2024 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical…
WESTLAKE VILLAGE, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced…
HOUSTON, Oct. 08, 2024 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc. (NASDAQ:BPTH) (“Bio-Path” or the “Company”), a biotechnology company leveraging its…
Company announcement – No. 48 / 2024 Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism U.S. Food…
Dr. Yakov Freed, developer of ENCER Photo credit: ENCER DOVER, Del., Oct. 08, 2024 (GLOBE NEWSWIRE) — ENCER, the groundbreaking…
SALT LAKE CITY, Oct. 08, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and…